Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Total Stockholders Equity : ¥41,874 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co Total Stockholders Equity?

Jiangsu Hengrui Pharmaceuticals Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥41,874 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Jiangsu Hengrui Pharmaceuticals Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥6.56. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Jiangsu Hengrui Pharmaceuticals Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Jiangsu Hengrui Pharmaceuticals Co Total Stockholders Equity Historical Data

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Hengrui Pharmaceuticals Co Total Stockholders Equity Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

24,775.33

30,504.30

35,002.96

37,823.56

40,465.80

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															38,891.81	38,860.61	39,636.90	40,465.80	41,873.51

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Jiangsu Hengrui Pharmaceuticals Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(41873.505	-	0)	/	6379
	=	6.56

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Jiangsu Hengrui Pharmaceuticals Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	78.398)	/	41873.505
	=	0.00

Jiangsu Hengrui Pharmaceuticals Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Jiangsu Hengrui Pharmaceuticals Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047

Website

http://www.hrs.com.cn

Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.

Executives

Zhang Lian Shan	Directors, senior managers
Sun Xu Gen	senior management
Yuan Kai Hong	senior management
Zou Jian Jun	senior management
	senior management
Zhang Yue Hong	senior management
Liu Xiao Han	senior management
Zhou Yun Shu	Directors, senior managers
Liao Cheng	senior management
Wang Hong Sen	senior management
Zhou Song	senior management
Tao Wei Kang	senior management
Jiang Su Mei	senior management
Dai Hong Bin	Directors, senior managers
Sun Jie Ping	Directors, senior managers

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Headlines

No Headlines